Rapid Acting Insulin Market Analysis
The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$11. 17 billion by 2032, from US$7. 36 billion in 2023. The market is mainly driven by growth rate of diabetes and the rise in investment in research and development for human recombinant insulin.
Rapid Acting Insulin Industry Overview
...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian